ALPHARETTA, Ga., July 24, 2018 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussingfinancial results and business highlights for the second quarter 2018 on Tuesday, Aug. 7 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that
The conference call will be hosted by Joe Woody, chief executive officer, and Steve Voskuil, chief financial officer.
To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcast of the call and a related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/.
A replay of the conference call will be available Aug. 7 at noon ET by dialing 877-344-7529 in the United States and entering passcode 10122367. It will be available for one week. A replay of the webcast also will be accessible in the Investors section of the website, approximately one hour following the completion of the conference call.
About Avanos Medical, Inc.Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com.
View original content:http://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-second-quarter-2018-financial-results-300685091.html
SOURCE Avanos Medical, Inc.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All